Market Overview

Neurotrope +18.2% Premarket @$17.90; Co to Releases Results from Phase 2 Trial in Moderate to Severe Alzheimer's on May 1, 2017

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News Pre-Market Outlook Movers

 

Related Articles (PRAN + NTRP)

Partner Center